Wave Life Sciences Balance Sheet
NASDAQ: WVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Wave Life Sciences financial position
At the end of fiscal 2025, Wave Life Sciences reported total assets of $638.5 million, up 81.3% from a year earlier against total liabilities of $112.3 million. Shareholders' equity stood at $518.4 million, or 81.2% of assets. The company held $602.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 6.47, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Wave Life Sciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 602.07M | 302.08M | 200.35M | 88.50M | 150.56M | 184.50M | 147.16M | 174.82M | 142.50M | 150.29M |
| Receivables | 1.28M | 1.42M | 21.09M | — | — | 30.00M | 20.00M | 10.00M | 1.00M | — |
| Total Current Assets | 614.81M | 320.39M | 235.37M | 98.54M | 162.56M | 230.04M | 185.48M | 202.27M | 150.49M | 151.99M |
| Property, Plant & Equipment | 7.41M | 10.13M | 13.08M | 17.28M | 22.27M | 29.20M | 36.37M | 39.93M | 27.33M | 8.61M |
| Total Assets | 638.50M | 352.21M | 274.95M | 146.39M | 207.01M | 279.24M | 284.25M | 295.94M | 181.84M | 164.81M |
| Accounts Payable | 15.70M | 16.26M | 12.84M | 16.91M | 7.28M | 13.79M | 9.07M | 13.09M | 7.60M | 4.94M |
| Total Current Liabilities | 95.06M | 110.95M | 186.44M | 71.52M | 64.20M | 121.04M | 118.15M | 130.04M | 18.19M | 12.15M |
| Total Liabilities | 112.27M | 134.82M | 227.44M | 183.60M | 166.63M | 188.59M | 212.64M | 214.72M | 34.36M | 22.07M |
| Shareholders' Equity | 518.36M | 209.51M | 39.63M | -45.09M | 32.50M | 82.78M | 63.73M | 73.35M | 139.61M | 134.60M |
| Retained Earnings | -1.33B | -1.12B | -1.02B | -967.34M | -805.51M | -683.27M | -533.36M | -339.72M | -192.72M | -90.48M |
| Net Cash (Debt) | 602.07M | 302.08M | 200.35M | 88.50M | 150.56M | 184.50M | 147.16M | 174.82M | 142.50M | 150.29M |
| Shares Outstanding | 187.66M | 153.04M | 119.16M | 86.92M | 59.84M | 48.78M | 34.34M | 29.47M | 27.83M | 23.50M |
This table shows 10 annual periods of Wave Life Sciences's balance sheet, from FY 2025 back to FY 2016, across 12 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow WVE's reporting calendar. What is a balance sheet?